Evidence map›Paper›PMID 41828640›Full record

ReviewInternational journal of molecular sciences2026

Membranous Nephropathy: Antigenic Landscape and a Novel Pathogenetic Model.

Irina Zdravkova, Eduard Tilkiyan, Desislava Bozhkova, Yovko Ronchev, Boris Kirilov, Teodor Kuskunov, Atanas Lambrev

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Irina ZdravkovaDepartment of Propaedeutics of Internal Diseases, Medical Faculty, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.ORCID 0000-0003-1362-0121
Eduard TilkiyanNephrology Clinic, University Hospital "Kaspela", 4000 Plovdiv, Bulgaria.ORCID 0000-0002-4091-4312
Desislava BozhkovaDepartment of General and Clinical Pathology, Faculty of Medicine, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.ORCID 0000-0002-7802-0576
Yovko RonchevClinical Laboratory, University Hospital "Kaspela", 4000 Plovdiv, Bulgaria.ORCID 0000-0002-4674-7949
Boris KirilovNephrology Clinic, University Hospital "Kaspela", 4000 Plovdiv, Bulgaria.
Teodor KuskunovDepartment of Propaedeutics of Internal Diseases, Medical Faculty, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.ORCID 0009-0009-1745-3579
Atanas LambrevNephrology Clinic, University Hospital "Kaspela", 4000 Plovdiv, Bulgaria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Membranous nephropathy is a disease that has been well documented, yet its etiopathogenesis has not been fully clarified and the distinction between its primary and secondary forms has not been completely categorized. The discovery of new antigens and antibodies reveals different percentages of positivity in secondary membranous nephropathy, which is a cause of great confusion and ambiguity not only in diagnosis but also in the choice of a therapeutic approach. The aim of this review is to summarize the literature on newly discovered antigens and antibodies, and to propose a pathogenetic model based on the role of the complement system and its activation pathways. In this model, antigens are categorized based on the type of immunoglobulin deposits and the putative complement pathways that they activate, which can help to differentiate primary from secondary membranous nephropathy. The model also reflects how the deposition of foreign antigens in the basement membrane can activate both the lectin and classical complement pathways, which may explain why positive antibodies are observed in both primary and secondary forms of membranous nephropathy.

Indexed as

AutoantigensGlomerulonephritis, MembranousAnimalsComplement ActivationComplement System ProteinsHumansAutoantigensComplement System Proteinscomplement pathwaylectin pathwaypathogenesisprimary and secondary membranous nephropathytarget antigens

Identifiers

PMID41828640
PMCPMC12985607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.